IL1B and Hyperglycemia: Our experimental model of hyperglycemia resulted in a visible alteration of the HuASCs immunomodulatory properties and triggered an augmentation of the pro-inflammatory marker expression, including IL-1β and TNF-α at both the mRNA and the proteins levels.